CMS Open Payments · Program Year 2024
Aspero Medical, Inc.
Aspero Medical, Inc. reported $1,448.10 across General Payments, Research, and Ownership to 6 physicians and teaching hospitals across 6 transactions.
- $1.4K Below-median payer
- All-tracks total
- 6 Below-median volume
- Transactions
- 6 Below-median reach
- Recipients
- #1827
- of 1,925 companies
Aspero Medical, Inc. reported $1,448.10 across all CMS Open Payments tracks (General + Research + Ownership) to 6 physicians and teaching hospitals in Program Year 2024 - ranking #1827 of 1,925 reporting manufacturers (0.0% of the all-tracks industry total); General Payments alone were $1,448.10, averaging $241.35 per recipient.
Aspero Medical, Inc.'s payment reach score
Each tracked dimension is percentile-scored against the national companies corpus, then averaged across only the dimensions that apply to this company, a neutral scale measure of reporting activity, not a rating of quality, safety, or ethics.
Overall reach score
F
13/100
Total payments
F
10/100
Transaction volume
F
10/100
Physician reach
F
10/100
Payment type diversity
F
23/100
Data currency: Figures are rendered from the processed CMS Open Payments release. See our methodology for source dates and refresh cadence. Spot a figure that looks wrong? Report a correction.
CMS Sunshine Act warrant
Manufacturer aspero-medical-inc Aspero Medical, Inc.
$1.4K · #1827/1,925 · 0.0% industry · PY2024
- TOT $1.4K
- RANK #1827
- SHARE 0.0%
- TXN 6
- RCP 6
- CAT 2
- GEN $1.4K
- TOP1 58.7%
- PY 2024
Volume peers
Nearest volume peer: Diality Inc. ($1.5K)
Aspero Medical, Inc. sits among 1,925 manufacturers disclosing under the Physician Payments Sunshine Act. Volume peers below are nearest by all-tracks total, not corporate affiliates. Open the company rankings →
What the Data Shows for Aspero Medical, Inc.
Three separate CMS disclosure tracks feed the all-tracks total above - General, Research, and Ownership/Investment - each reported under its own rules and combined here for one comparable figure. For Aspero Medical, Inc. that figure is drawn almost entirely from the General Payments track (day-to-day consulting, meals, travel and speaking fees). CMS releases each Program Year roughly 12 months after it ends; the methodology page covers the full standardization basis.
The 2-category breakdown below covers general payments only (see our methodology for how research and ownership payments are reported separately). The largest general-payment category is "Consulting Fee" at $1.1K, accounting for 76.0% of this company's General Payments and 2 transactions.
General Payment Breakdown by Type
"Consulting Fee" leads Aspero Medical, Inc.'s 2-category general-payment breakdown at $1.1K, 76.0% of the reported total.
How Aspero Medical, Inc. divides its payments
How the reported total splits across payment categories
| Payment Type | Amount | Transactions | % of Total |
|---|---|---|---|
| Consulting Fee | $1.1K | 2 | 76.0% |
| Food and Beverage | $348.10 | 4 | 24.0% |
Recipient Concentration in General Payments
The five largest recipient relationships account for $1,448.10 (100.0%) of $1,448.10 in this company's General Payments records across 2 recipients.
General Payments scope note
Program Year 2024 General Payments view only: excludes research and ownership/investment records, so it is not the all-category company total above.
Largest General-Payment relationships for Aspero Medical, Inc.
The five named recipients with the highest reported General Payments from this company
- 1
Peter Draganov
$850.70 across 4 reported transactions
- 2
Vladimir Kushnir
$597.40 across 2 reported transactions
Compare this company's payment profile with similarly sized manufacturers in the company comparison tool, and consult the methodology for the CMS source scope.
Spend vs. Concentration
Aspero Medical, Inc. ranks #1827 of 1,925 by total payments (bottom 5% by spend) but is notably more concentrated than that alone would suggest -- #337 of 1,838 by HHI (top 18% most concentrated). Its payments land on an unusually narrow set of recipients for its spend size.
View all 12 companies in this HHI neighborhood as a list
- Forthright Medical - MT, LLC : $100.4K total payments, HHI 5198
- Solco Biomedical Corporation : $18.0K total payments, HHI 5197
- Zentech Inc. : $15.2K total payments, HHI 5181
- Ipsen Pharma SAS : $456.4K total payments, HHI 5180
- Omega Medical Imaging, LLC : $515.98 total payments, HHI 5180
- Dental Material Gesellschaft mbH : $7.3K total payments, HHI 5160
- Aspero Medical, Inc. (this company) : $1.4K total payments, HHI 5153
- Karl Storz Imaging, Inc. : $852.50 total payments, HHI 5150
- Iridex Corporation : $151.0K total payments, HHI 5149
- Dentsply Sirona Pty Limited : $34.5K total payments, HHI 5119
- FHC, Inc. : $19.6K total payments, HHI 5112
- GRT US Holding, Inc. : $32.4K total payments, HHI 5103
Similarly Concentrated Companies
Companies whose General Payments are spread across recipients about as (un)evenly as Aspero Medical, Inc.'s, measured by the same HHI concentration index above, not by payment size.
What HHI 2,500 means here
2,500 is the DOJ/FTC merger-guidelines threshold for "highly concentrated" markets; used here only as a familiar concentration reference, not a legal finding about Aspero Medical, Inc..
Companies with Similar Payment Volumes
Open a profile or compare a similar company's CMS-reported payment pattern with Aspero Medical, Inc..
Showing 6 of 1,924 companies with CMS-reported payment data.
Omeza LLC
imvaria inc.
Medtec LLC
AERAS, Inc.
Nurami Medical Inc
Put this to use
Aspero Medical, Inc. ranks #1827 of 1,925 by all-tracks total payments, led by "Consulting Fee".
- See how manufacturer spending compares across the full leaderboard. Top 100 by total payments
- Compare "Consulting Fee" spend across every manufacturer, not just Aspero Medical, Inc.. Payment type breakdowns
- New to Open Payments? Learn what these figures do and do not show. Read the guide
Reported payments reflect what companies disclosed to CMS; a payment is not evidence of wrongdoing.
Disclaimer
This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the CMS Open Payments program. Consult a qualified professional before making decisions based on this data.
Read our methodology - how this data is sourced, computed, and verified.
Every figure on PlainPharmaWatch is rendered directly from federal source data, no number is typed in by an editor. This page draws directly on federal source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of 2026-07-26.